Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
This paragraph explains how to identify dividend ETFs with the lowest management fees and compare options side by side.
27,460 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Li Lu’s Himalaya Capital is famous for a bold, value-driven stance and a striking concentration in just a few bets. T...
Medicare is tightening oversight on hospice providers amid rising admissions and fraud concerns. The crackdown could ...
A former employee has filed a class-action complaint against US Mortgage Corp. over a May 2025 data breach that expos...
Solana SOL faces a pivotal test as the $90 floor flips to a ceiling while trading volume wanes. Analysts warn that th...
Amazon launches a $200 billion AI-focused capex plan for 2026, with Trainium and Anthropic in the mix. Here’s what in...
The White House is pushing to repaint a nearby historic building, a move critics say would hurt the structure and dra...
A prominent crypto strategist questions the strength of Bitcoin’s latest move, warning traders to prepare for a sharp...
A 67-year-old with million 401K confronts looming RMDs that could produce a six-figure federal tax bill. Experts say ...
A lithium-tech company unveils a faster, higher-yield extraction method and is moving into commercial-scale productio...
Huron's latest revenue milestone grabbed headlines, but a large fund still trimmed its position. This article breaks ...
In a move that stirs controversy, a $1.7 billion fund is being created to compensate allies in a settlement tied to T...